1. Home
  2. CODX vs BNGO Comparison

CODX vs BNGO Comparison

Compare CODX & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • BNGO
  • Stock Information
  • Founded
  • CODX 2013
  • BNGO 2003
  • Country
  • CODX United States
  • BNGO United States
  • Employees
  • CODX N/A
  • BNGO N/A
  • Industry
  • CODX Medical/Dental Instruments
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CODX Health Care
  • BNGO Industrials
  • Exchange
  • CODX Nasdaq
  • BNGO Nasdaq
  • Market Cap
  • CODX 22.0M
  • BNGO 24.3M
  • IPO Year
  • CODX 2017
  • BNGO 2018
  • Fundamental
  • Price
  • CODX $0.71
  • BNGO $5.36
  • Analyst Decision
  • CODX Hold
  • BNGO Hold
  • Analyst Count
  • CODX 1
  • BNGO 3
  • Target Price
  • CODX $1.50
  • BNGO $60.00
  • AVG Volume (30 Days)
  • CODX 139.9K
  • BNGO 266.9K
  • Earning Date
  • CODX 03-13-2025
  • BNGO 03-04-2025
  • Dividend Yield
  • CODX N/A
  • BNGO N/A
  • EPS Growth
  • CODX N/A
  • BNGO N/A
  • EPS
  • CODX N/A
  • BNGO N/A
  • Revenue
  • CODX $7,321,012.00
  • BNGO $33,334,000.00
  • Revenue This Year
  • CODX N/A
  • BNGO N/A
  • Revenue Next Year
  • CODX N/A
  • BNGO $6.18
  • P/E Ratio
  • CODX N/A
  • BNGO N/A
  • Revenue Growth
  • CODX 57.16
  • BNGO N/A
  • 52 Week Low
  • CODX $0.65
  • BNGO $4.75
  • 52 Week High
  • CODX $2.23
  • BNGO $81.00
  • Technical
  • Relative Strength Index (RSI)
  • CODX 43.93
  • BNGO 34.06
  • Support Level
  • CODX $0.69
  • BNGO $5.05
  • Resistance Level
  • CODX $0.73
  • BNGO $6.32
  • Average True Range (ATR)
  • CODX 0.04
  • BNGO 0.50
  • MACD
  • CODX 0.00
  • BNGO 0.31
  • Stochastic Oscillator
  • CODX 42.31
  • BNGO 38.85

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: